JPS5869875A - ４―ｔｅｒｔ―ブチル―５―ハロメチル―１．３―ジオキリレン―２―オン - Google Patents

４―ｔｅｒｔ―ブチル―５―ハロメチル―１．３―ジオキリレン―２―オン

Info

Publication number: JPS5869875A
Authority: JP; Japan
Prior art keywords: butyl; compound; dioxolen; formula; reaction
Prior art date: 1981-10-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP16860381A

Other languages

English (en)

Japanese (ja)

Other versions

JPH034552B2 (fr

Inventor

Goro Tsukamoto

悟郎塚本

Fumio Sakamoto

坂本　文夫

Shoji Ikeda

池田　昇司

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kanebo Ltd

Original Assignee

Kanebo Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-10-23

Filing date

1981-10-23

Publication date

1983-04-26

1981-10-23 Application filed by Kanebo Ltd filed Critical Kanebo Ltd

1981-10-23 Priority to JP16860381A priority Critical patent/JPS5869875A/ja

1983-04-26 Publication of JPS5869875A publication Critical patent/JPS5869875A/ja

1991-01-23 Publication of JPH034552B2 publication Critical patent/JPH034552B2/ja

Status Granted legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 claims abstract description 32
238000000034 method Methods 0.000 claims abstract description 17
239000003795 chemical substances by application Substances 0.000 claims abstract description 13
230000002140 halogenating effect Effects 0.000 claims abstract description 9
125000005843 halogen group Chemical group 0.000 claims abstract description 5
239000003960 organic solvent Substances 0.000 claims abstract description 3
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims abstract 4
238000006243 chemical reaction Methods 0.000 claims description 21
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 10
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 9
229910052794 bromium Inorganic materials 0.000 claims description 9
229910052801 chlorine Inorganic materials 0.000 claims description 9
239000000460 chlorine Substances 0.000 claims description 7
125000001309 chloro group Chemical group Cl* 0.000 claims description 5
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
125000000746 allylic group Chemical group 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
238000010992 reflux Methods 0.000 claims description 4
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 3
VAYTZRYEBVHVLE-UHFFFAOYSA-N 1,3-dioxol-2-one Chemical compound O=C1OC=CO1 VAYTZRYEBVHVLE-UHFFFAOYSA-N 0.000 claims description 2
MARXMDRWROUXMD-UHFFFAOYSA-N 2-bromoisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(Br)C(=O)C2=C1 MARXMDRWROUXMD-UHFFFAOYSA-N 0.000 claims description 2
150000008282 halocarbons Chemical class 0.000 claims description 2
229930195733 hydrocarbon Natural products 0.000 claims description 2
150000002430 hydrocarbons Chemical class 0.000 claims description 2
WDRFYIPWHMGQPN-UHFFFAOYSA-N 2-chloroisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(Cl)C(=O)C2=C1 WDRFYIPWHMGQPN-UHFFFAOYSA-N 0.000 claims 1
239000004215 Carbon black (E152) Substances 0.000 claims 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 1
229910052753 mercury Inorganic materials 0.000 claims 1
239000003814 drug Substances 0.000 abstract description 5
229940079593 drug Drugs 0.000 abstract description 3
230000000845 anti-microbial effect Effects 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical class C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 abstract 1
239000000243 solution Substances 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
241000894006 Bacteria Species 0.000 description 7
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 7
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
241000699670 Mus sp. Species 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
239000002904 solvent Substances 0.000 description 5
OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
238000001816 cooling Methods 0.000 description 4
238000000921 elemental analysis Methods 0.000 description 4
239000000203 mixture Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
HXXOPVULXOEHTK-UHFFFAOYSA-N 4-methyl-1,3-dioxol-2-one Chemical compound CC1=COC(=O)O1 HXXOPVULXOEHTK-UHFFFAOYSA-N 0.000 description 3
229940126062 Compound A Drugs 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
230000000844 anti-bacterial effect Effects 0.000 description 3
238000009835 boiling Methods 0.000 description 3
239000003607 modifier Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 2
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
241000193830 Bacillus <bacterium> Species 0.000 description 2
239000004342 Benzoyl peroxide Substances 0.000 description 2
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
235000019400 benzoyl peroxide Nutrition 0.000 description 2
MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
238000001035 drying Methods 0.000 description 2
229910052731 fluorine Inorganic materials 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
239000011630 iodine Substances 0.000 description 2
238000005259 measurement Methods 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
239000003921 oil Substances 0.000 description 2
239000012044 organic layer Substances 0.000 description 2
WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical group C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
229940127557 pharmaceutical product Drugs 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
238000005406 washing Methods 0.000 description 2
239000008096 xylene Substances 0.000 description 2
-1 1-ethyl Chemical group 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
229910001369 Brass Inorganic materials 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000007059 acute toxicity Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000010951 brass Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
239000012230 colorless oil Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012937 correction Methods 0.000 description 1
239000012043 crude product Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000034994 death Effects 0.000 description 1
231100000517 death Toxicity 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000004821 distillation Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
230000009036 growth inhibition Effects 0.000 description 1
150000003949 imides Chemical class 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
230000001678 irradiating effect Effects 0.000 description 1
210000003127 knee Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
229960002195 perazine Drugs 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
235000015497 potassium bicarbonate Nutrition 0.000 description 1
229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
239000011736 potassium bicarbonate Substances 0.000 description 1
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 1
JWHOQZUREKYPBY-UHFFFAOYSA-N rubonic acid Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(=O)C(C)(C)C5CC(=O)C34C)C2C1)C(=O)O JWHOQZUREKYPBY-UHFFFAOYSA-N 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
229960002317 succinimide Drugs 0.000 description 1
229950011008 tetrachloroethylene Drugs 0.000 description 1
230000035922 thirst Effects 0.000 description 1
231100000820 toxicity test Toxicity 0.000 description 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

JP16860381A 1981-10-23 1981-10-23 ４―ｔｅｒｔ―ブチル―５―ハロメチル―１．３―ジオキリレン―２―オン Granted JPS5869875A (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP16860381A JPS5869875A (ja)	1981-10-23	1981-10-23	４―ｔｅｒｔ―ブチル―５―ハロメチル―１．３―ジオキリレン―２―オン

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP16860381A JPS5869875A (ja)	1981-10-23	1981-10-23	４―ｔｅｒｔ―ブチル―５―ハロメチル―１．３―ジオキリレン―２―オン

Publications (2)

Publication Number	Publication Date
JPS5869875A true JPS5869875A (ja)	1983-04-26
JPH034552B2 JPH034552B2 (fr)	1991-01-23

Family

ID=15871114

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP16860381A Granted JPS5869875A (ja)	1981-10-23	1981-10-23	４―ｔｅｒｔ―ブチル―５―ハロメチル―１．３―ジオキリレン―２―オン

Country Status (1)

Country	Link
JP (1)	JPS5869875A (fr)

1981
- 1981-10-23 JP JP16860381A patent/JPS5869875A/ja active Granted

Also Published As

Publication number	Publication date
JPH034552B2 (fr)	1991-01-23

Publication	Publication Date	Title
Barsoum et al.	2006	Novel bis (1-acyl-2-pyrazolines) of potential anti-inflammatory and molluscicidal properties
DE68910550T2 (de)	1994-04-07	Sulfonamid-Verbindungen.
DE69018876T2 (de)	1995-08-24	Pyridazinon-Derivate.
Antoszczak et al.	2019	Anti-trypanosomal activity of doubly modified salinomycin derivatives
FR2557111A1 (fr)	1985-06-28	Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
FR2537584A1 (fr)	1984-06-15	Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique
DE3886674T2 (de)	1994-04-28	Substituierte Chromane und verwandte Verbindungen für die Behandlung von Asthma.
US3652579A (en)	1972-03-28	1-methyl-2-substituted 5-nitroimidazoles
FI66859C (fi)	1984-12-10	Foerfarande foer framstaellning av 4-aminotiofen-3-karboxylsyraderivat med fysiologisk verkan
US3948913A (en)	1976-04-06	New 5-nitrofuryl derivatives
US4044130A (en)	1977-08-23	Compositions for the control of microorganisms
AU2017333054B2 (en)	2019-11-21	Method for preparing phenylalanine compound
Birch et al.	1994	Syntheses of flosequinan: a novel 4-quinolone shown to be useful in congestive heart failure
TWI330187B (en)	2010-09-11	Synthesis of silyl camptothecins and silyl homocamptothecins
EP0067411B1 (fr)	1984-12-19	Dérivé de l'acide quinoléinecarboxylique, procédé pour sa préparation et agent bactéricide le contenant
SU764609A3 (ru)	1980-09-15	Способ получени производных бензимидазолкарбамата
JPS6054960B2 (ja)	1985-12-03	抗しゆよう性セプタシジン類似体
SE8005127L (sv)	1981-01-14	Sett att framstella 15-hydroxiimino-e-homoeburnanderivat
Mohite et al.	2011	Synthesis and antifungal activity of 3-aryl-1-(5-phenyl-1H-tetrazol-1-yl) prop-2-en-1-One
JPH034552B2 (fr)	1991-01-23
TW200306304A (en)	2003-11-16	Process for the preparation of bicyclic diketone salts
US2993891A (en)	1961-07-25	Butyrolactone derivatives
Arora et al.	2020	Antibacterial properties of new 5-substituted derivatives of rhodanine-3-propanoic acid
SU563913A3 (ru)	1977-06-30	Способ получени производных 1-фталазона
WO2011069236A1 (fr)	2011-06-16	Méthode de synthèse de l'hypocrelline